There were no significant differences in age, gender, tumor site, mucinous carcinoma, number of lymph nodes sampled, histological differentiation, and tumor markers (CEA, CA125, and CA199) between patients with recurrence and those without (Table 3). Here, CEACAM5 is linked to neoplasm.